MESO logo

Mesoblast Limited (MESO)

Profile

Full Name

Mesoblast Limited

Ticker

NASDAQ: MESO

Exchange

NASDAQ

Country

Australia

IPO

January 20, 2010

Indexes

Not included

Employees

73

Key Details

Price

$18.41(8.17%)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$17.17M(190.90% YoY)

Annual EPS

-$0.84(5.28% YoY)

Next earnings date

Feb 24, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jul 18, 25 Jefferies
Hold
Feb 7, 25 Piper Sandler
Overweight
Dec 23, 24 Jefferies
Hold
Dec 19, 24 Piper Sandler
Overweight
Jul 23, 24 Piper Sandler
Overweight
Jun 20, 24 Cantor Fitzgerald
Overweight
Jun 4, 24 Cantor Fitzgerald
Overweight
Sep 21, 23 Cantor Fitzgerald
Overweight
Aug 31, 23 Jefferies
Buy
Aug 31, 23 Cantor Fitzgerald
Overweight

Institutional Ownership

  • What is the ticker symbol for Mesoblast Limited?
  • Does Mesoblast Limited pay dividends?
  • What sector is Mesoblast Limited in?
  • What industry is Mesoblast Limited in?
  • What country is Mesoblast Limited based in?
  • When did Mesoblast Limited go public?
  • Is Mesoblast Limited in the S&P 500?
  • Is Mesoblast Limited in the NASDAQ 100?
  • Is Mesoblast Limited in the Dow Jones?
  • When was Mesoblast Limited's last earnings report?
  • When does Mesoblast Limited report earnings?

What is the ticker symbol for Mesoblast Limited?

The ticker symbol for Mesoblast Limited is NASDAQ:MESO

Does Mesoblast Limited pay dividends?

No, Mesoblast Limited does not pay dividends

What sector is Mesoblast Limited in?

Mesoblast Limited is in the Healthcare sector

What industry is Mesoblast Limited in?

Mesoblast Limited is in the Biotechnology industry

What country is Mesoblast Limited based in?

Mesoblast Limited is headquartered in Australia

When did Mesoblast Limited go public?

Mesoblast Limited's initial public offering (IPO) was on January 20, 2010

Is Mesoblast Limited in the S&P 500?

No, Mesoblast Limited is not included in the S&P 500 index

Is Mesoblast Limited in the NASDAQ 100?

No, Mesoblast Limited is not included in the NASDAQ 100 index

Is Mesoblast Limited in the Dow Jones?

No, Mesoblast Limited is not included in the Dow Jones index

When was Mesoblast Limited's last earnings report?

Mesoblast Limited's most recent earnings report was on August 28, 2025

When does Mesoblast Limited report earnings?

The next expected earnings date for Mesoblast Limited is February 24, 2026
On this page